Published in J Endocrinol on November 01, 1978
Calcitonin gene-related peptide is a potent vasodilator. Nature (1985) 6.13
The laryngeal mask airway for intraocular surgery: effects on intraocular pressure and stress responses. Br J Anaesth (1992) 3.26
Brain-computer interface technology: a review of the first international meeting. IEEE Trans Rehabil Eng (2000) 3.10
Haemodilution induces a hypercoagulable state. Br J Anaesth (1996) 2.88
Human calcitonin in the treatment of Paget's bone disease. Lancet (1971) 2.37
Plasma-immunoreactive-calcitonin in patients with non-thyroid tumours. Lancet (1974) 2.30
Bisphosphonates induce apoptosis in human breast cancer cell lines. Br J Cancer (2000) 2.12
Isolation and characterization of human calcitonin gene-related peptide. Nature (1984) 2.03
The role of the College of Medicine of South Africa Diploma in Anaesthesia in southern Africa. S Afr Med J (1999) 1.97
Isolation and chemical properties of porcine parathyroid hormone. Biochemistry (1971) 1.92
Affinity of calciferol analogues for 25-hydroxycholecalciferol receptors. Clin Sci Mol Med (1974) 1.83
Rifampicin and vitamin D metabolism. Clin Pharmacol Ther (1980) 1.78
Pharmacological magnetic resonance imaging: a new application for functional MRI. Trends Pharmacol Sci (2000) 1.78
Report of an IEEE task force--an IEEE opinion on research needs for biomedical engineering systems. IEEE Trans Biomed Eng (1986) 1.77
Epilepsy and employment. Community Health (Bristol) (1976) 1.75
A study of rotationally invariant and symmetric indices of diffusion anisotropy. Magn Reson Imaging (1999) 1.69
Potent vasodilator activity of calcitonin gene-related peptide in human skin. J Invest Dermatol (1986) 1.68
Magnesium exchange between blood and cerebrospinal fluid. Am J Physiol (1963) 1.67
Effect of thyrocalcitonin in man. Lancet (1966) 1.67
Co-localization of calcitonin gene-related peptide-like immunoreactivity with substance P in cutaneous, vascular and visceral sensory neurons of guinea pigs. Neurosci Lett (1985) 1.66
Bombesin: action on gut hormones and calcium in man. J Clin Endocrinol Metab (1982) 1.65
In vivo investigation into the effects of haemodilution with hydroxyethyl starch (200/0.5) and normal saline on coagulation. Br J Anaesth (1998) 1.61
Retracted Altered calcitonin gene in a young patient with osteoporosis. BMJ (1989) 1.55
A biological assay for calcitonin. J Endocrinol (1965) 1.53
Topical calcipotriol treatment in advanced breast cancer. Lancet (1991) 1.53
Stress-activated protein kinases: activation, regulation and function. Cell Signal (1997) 1.52
Effect of isoniazid on vitamin D metabolism and hepatic monooxygenase activity. Clin Pharmacol Ther (1981) 1.52
Reliability and sensitivity of joint space measurements in hand radiographs using computerized image analysis. J Rheumatol (2001) 1.49
Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens. Lancet (1981) 1.47
Somatotopographic organization in the second somatosensory area of M. fascicularis. J Comp Neurol (1980) 1.47
Neutrophils from patients undergoing hip surgery exhibit enhanced movement under spinal anaesthesia compared with general anaesthesia. Can J Anaesth (1992) 1.46
A physiological role for calcitonin: protection of the maternal skeleton. Lancet (1979) 1.44
Retinoids cause apoptosis in pancreatic cancer cells via activation of RAR-gamma and altered expression of Bcl-2/Bax. Br J Cancer (2002) 1.44
The calcitonin-like sequence of the beta CGRP gene. FEBS Lett (1986) 1.43
The effects on increasing cardiac output with adrenaline or isoprenaline on arterial haemoglobin oxygen saturation and shunt during one-lung ventilation. Anaesth Intensive Care (2000) 1.42
A prospective study of anaesthesia for quinsy tonsillectomy. Anaesthesia (1995) 1.39
Chemistry, physiology, and therapeutic applications of calcitonin. Arthritis Rheum (1980) 1.34
A chick bioassay for parathyroid hormone. Endocrinology (1973) 1.32
Tobacco smoking, pregnancy estrogens, and birth weight. Epidemiology (1990) 1.31
Partial nucleotide sequence of human calcitonin precursor mRNA identifies flanking cryptic peptides. Nature (1982) 1.31
Thymic and parathyroid origin of calcitonin in man. Lancet (1968) 1.31
Organization of somatosensory receptive fields in cortical areas 7b, retroinsula, postauditory and granular insula of M. fascicularis. J Comp Neurol (1980) 1.30
Endothelial nitric oxide synthase gene-deficient mice demonstrate marked retardation in postnatal bone formation, reduced bone volume, and defects in osteoblast maturation and activity. Am J Pathol (2001) 1.29
Endotoxaemia in exhausted runners after a long-distance race. S Afr Med J (1988) 1.27
Leptin and insulin growth factor I in relation to breast cancer (Greece). Cancer Causes Control (2000) 1.27
Radiological evidence of a dose-related response to long-term treatment of Paget's disease with human calcitonin. Br J Radiol (1974) 1.26
Acceleration threshold detection during short anterior and posterior perturbations on a translating platform. Gait Posture (2003) 1.24
Peripheral neural correlates of magnitude of cutaneous pain and hyperalgesia: simultaneous recordings in humans of sensory judgments of pain and evoked responses in nociceptors with C-fibers. J Neurophysiol (1984) 1.24
1,25-dihydroxyvitamin-D-receptor in breast cancer cells. Lancet (1980) 1.22
Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms. Proc Natl Acad Sci U S A (1995) 1.21
Olfactory adenylate cyclase of the rat. Stimulation by odorants and inhibition by Ca2+. Biochem J (1986) 1.20
Effect of calcitonin on vitamin D metabolism. Nature (1972) 1.19
A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer. Br J Cancer (1998) 1.19
Phosphaturic effect of thyrocalcitonin. Lancet (1966) 1.17
Somatic submodality distribution within the second somatosensory (SII), 7b, retroinsular, postauditory, and granular insular cortical areas of M. fascicularis. J Comp Neurol (1980) 1.17
Effect of calcitonin gene-related peptide on contraction of striated muscle in the mouse. Neurosci Lett (1985) 1.17
Immunoreactive calcitonin production by human lung carcinoma cells in culture. Br J Cancer (1975) 1.16
Interrelations of calcium-regulating hormones during normal pregnancy. Br Med J (Clin Res Ed) (1981) 1.16
Peripheral neural mechanisms of cutaneous hyperalgesia following mild injury by heat. J Neurosci (1982) 1.16
Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population. Br J Cancer (2001) 1.16
Structure-function studies in parathyroid hormone. Proc R Soc Med (1971) 1.15
Human calcitonin gene related peptide: a potent endogenous vasodilator in man. Clin Sci (Lond) (1986) 1.15
Peptides from the calcitonin genes: molecular genetics, structure and function. Biochem J (1988) 1.14
Healing of the bones in juvenile Paget's disease treated by human calcitonin. Br J Radiol (1974) 1.14
Effects of peptides from the calcitonin genes on bone and bone cells. Q J Exp Physiol (1988) 1.14
1,25-dihydroxyvitamin D3 specifically binds to a human breast cancer cell line (T47D) and stimulates growth. Biochem Biophys Res Commun (1981) 1.13
The mode of action of thyrocalcitonin. Lancet (1966) 1.13
Biochemical markers in bronchial carcinoma. Br J Cancer (1977) 1.12
Magnesium sulphate for the control of spasms in severe tetanus. Anaesthesia (1998) 1.12
A simplified perfusion method for study of calcium equilibrium in isolated bone. J Physiol (1968) 1.12
Vitamin D receptor-dependent antitumour effects of 1,25-dihydroxyvitamin D3 and two synthetic analogues in three in vivo models of prostate cancer. BJU Int (2002) 1.10
Relative deficiency of plasma-calcitonin in normal women. Lancet (1978) 1.10
'Calcium-activated' intracellular calcium elevation: a novel mechanism of osteoclast regulation. Biochem Biophys Res Commun (1989) 1.10
Effect of rifampicin and isoniazid on vitamin D metabolism. Clin Pharmacol Ther (1982) 1.10
A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer. Br J Cancer (2002) 1.09
Deaths associated with anaesthesia--a lesson for South Africa. S Afr Med J (1996) 1.09
Inhibiting the hyperreflexic bladder with electrical stimulation in a spinal animal model. Neurourol Urodyn (1993) 1.08
Mercuric chloride-, gold sodium thiomalate-, and D-penicillamine-induced antinuclear antibodies in mice. Toxicol Appl Pharmacol (1986) 1.08
EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro. Br J Pharmacol (1998) 1.08
Calcitonin gene-related peptide: potent vasodilator and major product of calcitonin gene. Lancet (1985) 1.08
Effects of nucleotides, hormones, ions, and 1,25-dihydroxycholecalciferon on 1,25-dihydroxycholecalciferol production in isolated chick renal tubules. Clin Sci Mol Med (1974) 1.08
Vasodilatation by calcitonin gene-related peptide and by substance P: a comparison of their effects on resistance and capacitance vessels of human forearms. Circulation (1988) 1.07
The construction and partial characterization of plasmids containing complementary DNA sequences to human calcitonin precursor polyprotein. Biochem J (1981) 1.07
Regulation of vitamin-D metabolism without parathyroid hormone. Lancet (1973) 1.07
Calcitonin and 1,25-dihydroxyvitamin D3 receptors in human breast cancer cell lines. Cancer Res (1980) 1.06
Insulin-like growth factor 1 in hepatocellular carcinoma and metastatic liver cancer in men. Int J Cancer (2000) 1.06
Intrapleural bupivacaine analgesia in chest trauma: a randomized double-blind controlled trial. Injury (1991) 1.06
The bisphosphonate zoledronic acid impairs Ras membrane [correction of impairs membrane] localisation and induces cytochrome c release in breast cancer cells. Br J Cancer (2002) 1.05
Human calcitonin. Nature (1968) 1.05
Effect of parathyroid extract on vitamin-D metabolism. Lancet (1972) 1.05
Distribution of calcitonin gene-related peptide in the rat peripheral nervous system with reference to its coexistence with substance P. Neuroscience (1985) 1.05
Effect of prolactin on vitamin D metabolism. Mol Cell Endocrinol (1976) 1.05